MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Multi-stakeholder focus group study to develop recommendations of ways to improve treatment burden and capacity in Parkinson’s disease

QY. Tan, S. Fraser, H. Roberts, K. Ibrahim (Southampton, United Kingdom)

Meeting: 2023 International Congress

Abstract Number: 1920

Keywords: Parkinson’s

Category: Quality Of Life/Caregiver Burden in Movement Disorders

Objective: To develop recommendations of ways to improve treatment burden and capacity in Parkinson’s disease (PD)

Background: Our research has identified potentially modifiable factors of treatment burden (workload of healthcare) and capacity (ability to manage treatment burden) in people with Parkinson’s (PwP) and their caregivers. These include challenges attending appointments, poor interactions with healthcare professionals, unsatisfactory information provision, difficulties managing medications, and problems enacting personal life adaptations. Addressing these factors could improve healthcare outcomes and quality of life for PwP and their caregivers.

Method: A qualitative study involving focus group discussion with a purposive sample of PwP, caregivers and healthcare professionals was conducted. Online focus groups were held and data analysed thematically.

Results: Three focus group discussions including a total of 11 participants (3 PwP, 1 caregiver, and 7 healthcare professionals) were conducted. Recommendations of ways to improve the key issues of treatment burden and capacity in PD were categorised into four interlinked themes: 1) Increasing visibility of PD, 2) Improving availability and organisation of healthcare services, 3) Improving interactions with healthcare professionals and information provision, and 4) Embracing the role of technology. For PwP and caregivers, the positive labelling of PD could help prioritise access to healthcare professionals. At an individual provider level, clear communication, expectation setting, and appropriate signposting to information and available services from healthcare professionals based on individuals’ needs and preferences could be beneficial. At a system level, increasing education and awareness about the complexity of PD, flexible appointment structures, improving communication between healthcare services, access to shared medical online records, and development of integrated care systems and single-point of access could improve the experiences of PwP and caregivers.

Conclusion: The focus groups identified potentially important areas where change at the individual and/or system level might reduce treatment burden and enhance capacity for PwP and caregivers. The wider utilisation of readily available resources and support from Parkinson’s UK by PwP, caregivers, and healthcare professionals could be an important first step.

To cite this abstract in AMA style:

QY. Tan, S. Fraser, H. Roberts, K. Ibrahim. Multi-stakeholder focus group study to develop recommendations of ways to improve treatment burden and capacity in Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/multi-stakeholder-focus-group-study-to-develop-recommendations-of-ways-to-improve-treatment-burden-and-capacity-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/multi-stakeholder-focus-group-study-to-develop-recommendations-of-ways-to-improve-treatment-burden-and-capacity-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley